AbbVie Inc. (4AB.DU) Stock Overview
Explore AbbVie Inc.’s financial performance, market position, analyst ratings, and future outlook.
AbbVie Inc. (4AB.DU)
Key Financials
Key Financials
Market Cap
390.5B
P/E Ratio
72.00
EPS (TTM)
$5.71
ROE
-1.37%
4AB.DU Stock Analysis & Investment Overview (DUS)
Our AI-powered analysis of AbbVie Inc. (DUS: 4AB.DU) gives investors deep insight into how the stock performs on the DUS exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, AbbVie Inc.'s DUS-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of 4AB.DU on the DUS shows an RSI of 52.65, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $208.90 for the DUS listing.
Key metrics behind AbbVie Inc.'s DUS-traded stock include a P/E ratio of 72.00 and a market capitalization of 390.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of 4AB.DU on the DUS.